Neuroprotection by taurine and taurine analogues

Advances in Experimental Medicine and Biology

Volumn 583, Issue , 2006, Pages 299-306

  Ward, Roberta ^a   Cirkovic Vellichovia, Tanya ^a   Ledeque, Florence ^a   Tirizitis, Gunars ^b   Dubars, Gunars ^b   Datla, Krishna ^c   Dexter, David ^c   Heushling, Paul ^d   Crichton, Robert ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b LATVIAN INSTITUTE OF ORGANIC SYNTHESIS   (Latvia)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF LUXEMBOURG   (Luxembourg)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84934437299     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-0-387-33504-9_33     Document Type: Conference Paper

References (22)

1. Banks, M. A., Porter, D. W., Pailes, W. H., Schwegler-Berry, D., Martin, W. G., and Castranova, V., 1991, Taurine content of isolated rat alveolar type I cells, Comp. Biochem. Physiol. B 100:795-799.
2. Barua, M., Liu, Y., and Quinn, M. R., 2001, Taurine chloramine inhibits inducible nitric oxide synthase and TNF-α gene expression in activated alveolar macrophages: decreased NF-KB activation and IKB kinase activity, J. Immunol. 167:2275-2281.
3. Beauchamp, C. and Fridovich, I., 1971, Superoxide dismutase: Improved assays and an assay applicable to acrylamide gels, Anal. Biochem. 44:276-278.
4. Carmen, S., Gage, F. H., and Shults, C. W., 1991, Partial lesion of the substanis nigra: relation between extent of lesion and rotational behaviour, Brain Res. 553:275-283.
5. Chorazy, M., Kontny, E., Marcinkiewicz, J., and Maslinski, W. 2002, Taurine chloramine modulates cytokine production by human peripheral blood mononuclear cells, Amino Acids 23:407-413.
6. Crichton, R. R. and Ward, R. J., 2005, in Metal-Based Neurodegeneration: From Molecular Mechanisms to Therapeutic Strategies, J Wiley and Sons, Chichester, UK, in press.
7. Dahchour, A. and De Witte, P., 2003, Effects of acamprosate on excitatory amino acids during multiple ethanol withdrawal period, Alcohol Clin. Exp. Res. 27:465-470.
8. Datla, K. P., Blunt, S. B., and Dexter, D. T., 2001, Chronic L-DOPA administration is not toxic to the remaining dopaminergic nigrostriatal neurons, but instead may promote their functional recovery, in rats with partial 6-OHDA or FeCl(3) nigrostriatal lesions, Movement Disord. 16:424-434.
9. Della Corte, L., Crichton, R. R., Duburs, G., Nolan, K., Tipton, K. F., Tirizitis, G., and Ward, R. J., 2002, The use of taurine analogues to investigate taurine functions and their potential therapeutic application, Amino Acids 23:367-379.
10. Hissin, P. J. and Hilf, R., 1976, A fluorometric method for the determination of reduced glutathione in tissues, Anal. Biochem. 74:214-216.
11. Kim, H. W., Kim, J. H., An, H. S., Park, K. K., Kim, B. K., and Park, T., 2003, Myo-inositol restores the inflammation-induced down-regulation of taurine transport by the murine macrophage cell line, RAW 264.7, Life Sci. 73:2477-2489.
12. Liu, Y., Schuller-Levis, G., and Quinn, M. R., 1999, Monocyte chemoattractant protein-1 and macrophage inflammatory protein-2 production is inhibited by taurine chloramine in rat C6 glioma cells, Immunol. Lett. 70:9-14.
13. Mark, L. P., Prost, R. W., Ulmer, J. L., Smith, M. M., Daniels, D. L., Strottmann, J. M., Douglas Brown, W., and Hacein-Bey, L., 2001, Pictorial review of glutamate excitotoxicity: fundamental concepts for neuroimaging, Am. J. Neuroradiol. 22:1813-1824.
14. Olszowski, S., Olszowska, E., Kusior, D., and Szneler, E., 2002, Sulphoacetaldehyde as a product of taurine chloramine peroxidation, at site of inflammation Amino Acids 22:145-153.
15. 2+ sequestration by taurine, Biochem. Pharmacol. 58:1123-1131.
16. Park, E., Jia, J., Quinn, M. R., and Schuller-Lewis, G., 2002, Taurine chloramine inhibits lymphocyte proliferation and decreases cytokine production in activated human leukocytes, Clin. Immunol. 102:179-184.
17. Paxinos, G. and Watson, C. 1986, The Rat Brain in Stereotaxic Co-ordinates, 2nd edn, Academic Press, London.
18. Perese, D. A., Ulman, J., Viola, J., Ewing, S. E., and Bankiewicz, K. S., 1989, A 6-hydroxydopamine-induced selective Parkinsonian rat model, Brain Res. 494:285-293.
19. Peters, T. J. and Batt, R. M., 1985, Effect of predinosolone on small intestinal mucosa of the rat, Clin. Sci. 50:511-523.
20. Schuller-Levis, G. B. and Park, E., 2003, Taurine new implications for an old amino acid, FEMS Microbiol. Lett. 226:195-202.
21. Son, M., Ko, J. I., Kim W. B., Kang, H. K., and Kim, B. K., 1998, Taurine can ameliorate inflammatory bowel disease in rats, Adv. Exp. Med. Biol. 442:291-298.
22. Tappaz, M. L., 2004, Taurine biosynthetic enzymes and taurine transporter: molecular identification and regulations, Neurochem. Res. 29:83-96.